methyl salicylate has been researched along with Conjunctivitis, Allergic in 26 studies
methyl salicylate: used in over-the-counter liniments, ointments, lotions for relief of musculoskeletal aches and pains; has hemolytic effect on human & sheep erythrocytes; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5990
methyl salicylate : A benzoate ester that is the methyl ester of salicylic acid.
Conjunctivitis, Allergic: Conjunctivitis due to hypersensitivity to various allergens.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study investigated the clinical efficacy, safety and dose-response relationship of SLIT in children suffering from rhinoconjunctivitis with/without asthma." | 2.72 | Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. ( Jacobsen, L; Koivikko, A; Ljørring, C; Savolainen, J; Valovirta, E, 2006) |
| "All subjects had moderate to severe hay fever symptoms, but at inclusion none reported asthma with need of daily treatment." | 2.70 | Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). ( Dreborg, S; Ferdousi, HA; Halken, S; Høst, A; Jacobsen, L; Koivikko, A; Koller, DY; Möller, C; Niggemann, B; Norberg, LA; Urbanek, R; Valovirta, E; Wahn, U, 2002) |
| "High-dose, subcutaneous IT is efficacious and safe in patients with severe birch pollen rhinoconjunctivitis and asthma." | 2.70 | The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. ( Bødtger, U; Jacobi, HH; Malling, HJ; Poulsen, LK, 2002) |
| "Five patients with seasonal allergic conjunctivitis (SAC) and five healthy subjects were included for validation purposes." | 1.38 | Conjunctival provocation with airborne allergen in patients with atopic keratoconjunctivitis. ( Gafvelin, G; Montan, PG; Nivenius, E; Van der Ploeg, I; Van Hage, M, 2012) |
| " High dosages of allergen were more effective while mode of dosing up did not seem to matter." | 1.35 | CD-sens: a biological measure of immunological changes stimulated by ASIT. ( Cardell, LO; Johansson, SG; Nopp, A; Oman, H, 2009) |
| "An episode of treated allergic rhinitis, rhinosinusitus, or conjunctivitis (ARC) was defined as the association of an oral antihistamine and a local antiallergic drug on the same prescription." | 1.34 | Short-term effect of pollen exposure on antiallergic drug consumption. ( Caillaud, D; Delmas, MC; Fuhrman, C; Lecadet, J; Sarter, H; Thibaudon, M; Zeghnoun, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (61.54) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, W | 1 |
| Kishimoto, T | 1 |
| Takaiwa, F | 1 |
| Fukuda, K | 1 |
| Buczyłko, K | 1 |
| van der Werf, JF | 1 |
| Boot, D | 1 |
| van Ree, R | 1 |
| Ellis, AK | 1 |
| Tenn, MW | 1 |
| Steacy, LM | 1 |
| Adams, DE | 1 |
| Day, AG | 1 |
| Walker, TJ | 1 |
| Nolte, H | 1 |
| Couroux, P | 1 |
| Ipsen, H | 1 |
| Stage, BS | 2 |
| Damkjaer, JT | 1 |
| Steffensen, MA | 1 |
| Salapatek, AM | 1 |
| Lund, K | 1 |
| Würtzen, PA | 1 |
| Pfaar, O | 1 |
| Bachert, C | 1 |
| Kuna, P | 2 |
| Panzner, P | 2 |
| Džupinová, M | 1 |
| Klimek, L | 1 |
| van Nimwegen, MJ | 1 |
| Boot, JD | 1 |
| Yu, D | 1 |
| Opstelten, DJE | 1 |
| de Kam, PJ | 1 |
| Biedermann, T | 1 |
| Valovirta, E | 3 |
| Andersson, M | 1 |
| de Blay, F | 1 |
| Thrane, D | 1 |
| Jacobsen, SH | 1 |
| Winther, L | 1 |
| Caillaud, D | 2 |
| Martin, S | 1 |
| Segala, C | 1 |
| Besancenot, JP | 1 |
| Clot, B | 1 |
| Thibaudon, M | 2 |
| Moingeon, P | 1 |
| Floch, VB | 1 |
| Airouche, S | 1 |
| Baron-Bodo, V | 1 |
| Nony, E | 1 |
| Mascarell, L | 1 |
| Tagawa, Y | 1 |
| Namba, K | 1 |
| Nakazono, Y | 1 |
| Iwata, D | 1 |
| Ishida, S | 1 |
| Pauli, G | 2 |
| Larsen, TH | 1 |
| Rak, S | 2 |
| Horak, F | 1 |
| Pastorello, E | 1 |
| Valenta, R | 3 |
| Purohit, A | 1 |
| Arvidsson, M | 1 |
| Kavina, A | 1 |
| Schroeder, JW | 1 |
| Mothes, N | 1 |
| Spitzauer, S | 1 |
| Montagut, A | 1 |
| Galvain, S | 1 |
| Melac, M | 1 |
| André, C | 1 |
| Poulsen, LK | 2 |
| Malling, HJ | 2 |
| Nopp, A | 1 |
| Cardell, LO | 1 |
| Johansson, SG | 1 |
| Oman, H | 1 |
| Nivenius, E | 1 |
| Van der Ploeg, I | 1 |
| Gafvelin, G | 1 |
| Van Hage, M | 1 |
| Montan, PG | 1 |
| Movérare, R | 1 |
| Westritschnig, K | 1 |
| Svensson, M | 1 |
| Hayek, B | 1 |
| Bende, M | 1 |
| Sorva, R | 1 |
| Haahtela, T | 2 |
| Elfman, L | 1 |
| Laaidi, M | 1 |
| Laaidi, K | 1 |
| Rigollet, S | 1 |
| Jahnz-Rózyk, K | 1 |
| Targowski, T | 1 |
| Głodzinska-Wyszogrodzka, E | 1 |
| Płusa, T | 1 |
| Roever, AC | 1 |
| Heine, G | 1 |
| Zuberbier, T | 1 |
| Worm, M | 1 |
| Helintö, M | 1 |
| Renkonen, R | 1 |
| Tervo, T | 1 |
| Vesaluoma, M | 1 |
| Saaren-Seppälä, H | 1 |
| Kirveskari, J | 1 |
| Heinrich, C | 1 |
| Scheynius, A | 1 |
| Kihlström, A | 1 |
| Hedlin, G | 1 |
| Pershagen, G | 1 |
| Troye-Blomberg, M | 1 |
| Härfast, B | 1 |
| Lilja, G | 1 |
| Jacobsen, L | 2 |
| Ljørring, C | 1 |
| Koivikko, A | 2 |
| Savolainen, J | 1 |
| Ridolo, E | 1 |
| Albertini, R | 1 |
| Giordano, D | 1 |
| Soliani, L | 1 |
| Usberti, I | 1 |
| Dall'Aglio, PP | 1 |
| Fuhrman, C | 1 |
| Sarter, H | 1 |
| Delmas, MC | 1 |
| Zeghnoun, A | 1 |
| Lecadet, J | 1 |
| Jenmalm, MC | 1 |
| Van Snick, J | 1 |
| Cormont, F | 1 |
| Salman, B | 1 |
| Riediker, M | 1 |
| Monn, C | 1 |
| Koller, T | 1 |
| Stahel, WA | 1 |
| Wüthrich, B | 1 |
| Möller, C | 1 |
| Dreborg, S | 1 |
| Ferdousi, HA | 1 |
| Halken, S | 1 |
| Høst, A | 1 |
| Koller, DY | 1 |
| Niggemann, B | 1 |
| Norberg, LA | 1 |
| Urbanek, R | 1 |
| Wahn, U | 1 |
| Bødtger, U | 1 |
| Jacobi, HH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation[NCT02394600] | Phase 4 | 93 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
| A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Clinical Efficacy and Safety of SUBLIVAC FIX Birch Immunotherapy in Patients Suffering From Allergic Rhinitis/Rhinoconjunctivitis Caused by Birch Pollen.[NCT02231307] | Phase 3 | 406 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"To determine the effect of 4 months of treatment with Grastek® on the symptoms of birch pollen induced AR in participants with both timothy grass pollen-induced and birch pollen-induced allergen rhinitis (AR)~TNSS is comprised of the sum of 4 symptoms: runny nose, itchy nose sneezing and nasal congestion. Each of these symptoms are evaluated based on a 4 point Likert scale from 0-3. 0 = no symptoms, 1 = mild symptoms, 2 = moderate symptoms and 3 = severe symptoms. TNSS can therefore have a range from 0 to 12." (NCT02394600)
Timeframe: 4 months
| Intervention | Scores on a scale (Mean) |
|---|---|
| Grastek | 2.3 |
| Placebo | 2.2 |
1 review available for methyl salicylate and Conjunctivitis, Allergic
| Article | Year |
|---|---|
Allergen immunotherapy for birch pollen-allergic patients: recent advances.
Topics: Animals; Antigens, Plant; Betula; Clinical Trials as Topic; Conjunctivitis, Allergic; Desensitizatio | 2016 |
11 trials available for methyl salicylate and Conjunctivitis, Allergic
| Article | Year |
|---|---|
Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
Topics: Administration, Cutaneous; Adolescent; Adult; Allergens; Antigens, Plant; Asthma; Betula; Child; Con | 2017 |
Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
Topics: Administration, Sublingual; Adolescent; Adult; Aged; Allergens; Betula; Biomarkers; Conjunctivitis, | 2018 |
A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG
Topics: Adolescent; Adult; Aged; Betula; Conjunctivitis, Allergic; Female; Humans; Immunoglobulin E; Immunog | 2019 |
Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.
Topics: Adolescent; Adult; Aged; Allergens; Antigens, Plant; Asthma; Betula; Conjunctivitis, Allergic; Doubl | 2019 |
The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial.
Topics: Adolescent; Adult; Aged; Allergens; Betula; Child; Conjunctivitis, Allergic; Double-Blind Method; Hu | 2019 |
Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
Topics: Adult; Allergens; Anti-Allergic Agents; Betula; Biomarkers; Conjunctivitis, Allergic; Dibenzazepines | 2017 |
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Topics: Adult; Allergens; Anti-Allergic Agents; Betula; Conjunctivitis, Allergic; Desensitization, Immunolog | 2008 |
Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Topics: Administration, Topical; Adult; Antigens, CD1; Betula; Biopsy; Conjunctivitis, Allergic; Desensitiza | 2005 |
Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Topics: Administration, Sublingual; Adolescent; Allergens; Alnus; Betula; Case-Control Studies; Child; Child | 2006 |
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).
Topics: Adolescent; Asthma; Betula; Bronchial Provocation Tests; Child; Conjunctivitis, Allergic; Desensitiz | 2002 |
The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.
Topics: Adult; Allergens; Antibody Specificity; Betula; Conjunctivitis, Allergic; Desensitization, Immunolog | 2002 |
14 other studies available for methyl salicylate and Conjunctivitis, Allergic
| Article | Year |
|---|---|
Prophylactic and Therapeutic Effects of Oral Immunotherapy on Birch Pollen-Induced Allergic Conjunctivitis in Mice with a Rice-Based Edible Vaccine Expressing a Hypoallergenic Birch Pollen Allergen.
Topics: Administration, Oral; Allergens; Animals; Betula; Conjunctivitis, Allergic; Desensitization, Immunol | 2021 |
Effects of airborne birch pollen levels on clinical symptoms of seasonal allergic rhinoconjunctivitis.
Topics: Adult; Air Pollutants; Allergens; Betula; Conjunctivitis, Allergic; Female; Humans; Male; Middle Age | 2014 |
CD-sens: a biological measure of immunological changes stimulated by ASIT.
Topics: Allergens; Basophils; Betula; Conjunctivitis, Allergic; Desensitization, Immunologic; Humans; Immuno | 2009 |
Conjunctival provocation with airborne allergen in patients with atopic keratoconjunctivitis.
Topics: Adult; Aged; Air Pollution; Allergens; Betula; Conjunctiva; Conjunctivitis, Allergic; Cytokines; Fem | 2012 |
Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
Topics: Adolescent; Adult; Aged; Allergens; Antibody Specificity; Antigens, Plant; Asthma; Betula; Calcium-B | 2002 |
[Pollen counts and allergies in Burgundy: profile and perspectives].
Topics: Adolescent; Adult; Air; Allergens; Asthma; Betula; Child; Conjunctivitis, Allergic; Environmental Mo | 2003 |
Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
Topics: Administration, Inhalation; Adult; Allergens; Anti-Allergic Agents; Betula; Biomarkers; Chemokines, | 2003 |
Allergen-mediated modulation of CD23 expression is interferon-gamma and interleukin-10 dependent in allergic and non-allergic individuals.
Topics: Adult; Allergens; B-Lymphocytes; Betula; Cells, Cultured; Conjunctivitis, Allergic; Down-Regulation; | 2003 |
Direct in vivo monitoring of acute allergic reactions in human conjunctiva.
Topics: Acute Disease; Adult; Allergens; Betula; Cell Adhesion Molecules; Chemotaxis, Leukocyte; Conjunctiva | 2004 |
Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
Topics: Air Pollutants; Allergens; Betula; Chi-Square Distribution; Child, Preschool; Conjunctivitis, Allerg | 2005 |
Airborne pollen concentrations and the incidence of allergic asthma and rhinoconjunctivitis in northern Italy from 1992 to 2003.
Topics: Adult; Ambrosia; Animals; Animals, Domestic; Asthma; Betula; Conjunctivitis, Allergic; Female; Human | 2007 |
Short-term effect of pollen exposure on antiallergic drug consumption.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Allergic Agents; Antigens, Plant; Betula; Child; Child, P | 2007 |
Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children.
Topics: Allergens; Animals; Antibodies; Asthma; Betula; Cats; Child; Child Welfare; Conjunctivitis, Allergic | 2001 |
Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals.
Topics: Adult; Air Pollutants; Allergens; Betula; Conjunctivitis, Allergic; Environmental Exposure; Female; | 2001 |